208 related articles for article (PubMed ID: 22258401)
1. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
Knight SJ; Yau C; Clifford R; Timbs AT; Sadighi Akha E; Dréau HM; Burns A; Ciria C; Oscier DG; Pettitt AR; Dutton S; Holmes CC; Taylor J; Cazier JB; Schuh A
Leukemia; 2012 Jul; 26(7):1564-75. PubMed ID: 22258401
[TBL] [Abstract][Full Text] [Related]
2. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.
Salaverria I; Martín-Garcia D; López C; Clot G; García-Aragonés M; Navarro A; Delgado J; Baumann T; Pinyol M; Martin-Guerrero I; Carrió A; Costa D; Queirós AC; Jayne S; Aymerich M; Villamor N; Colomer D; González M; López-Guillermo A; Campo E; Dyer MJ; Siebert R; Armengol L; Beà S
Genes Chromosomes Cancer; 2015 Nov; 54(11):668-80. PubMed ID: 26305789
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
[TBL] [Abstract][Full Text] [Related]
6. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
Malek SN
Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
[TBL] [Abstract][Full Text] [Related]
7. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
Ouillette P; Collins R; Shakhan S; Li J; Peres E; Kujawski L; Talpaz M; Kaminski M; Li C; Shedden K; Malek SN
Blood; 2011 Sep; 118(11):3051-61. PubMed ID: 21795749
[TBL] [Abstract][Full Text] [Related]
8. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Göransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hjalgrim H; Syvänen AC; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
Genes Chromosomes Cancer; 2008 Aug; 47(8):697-711. PubMed ID: 18484635
[TBL] [Abstract][Full Text] [Related]
9. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
Edelmann J; Holzmann K; Miller F; Winkler D; Bühler A; Zenz T; Bullinger L; Kühn MW; Gerhardinger A; Bloehdorn J; Radtke I; Su X; Ma J; Pounds S; Hallek M; Lichter P; Korbel J; Busch R; Mertens D; Downing JR; Stilgenbauer S; Döhner H
Blood; 2012 Dec; 120(24):4783-94. PubMed ID: 23047824
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
Nadeu F; Clot G; Delgado J; Martín-García D; Baumann T; Salaverria I; Beà S; Pinyol M; Jares P; Navarro A; Suárez-Cisneros H; Aymerich M; Rozman M; Villamor N; Colomer D; González M; Alcoceba M; Terol MJ; Navarro B; Colado E; Payer ÁR; Puente XS; López-Otín C; López-Guillermo A; Enjuanes A; Campo E
Leukemia; 2018 Mar; 32(3):645-653. PubMed ID: 28924241
[TBL] [Abstract][Full Text] [Related]
11. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
Schweighofer CD; Coombes KR; Majewski T; Barron LL; Lerner S; Sargent RL; O'Brien S; Ferrajoli A; Wierda WG; Czerniak BA; Medeiros LJ; Keating MJ; Abruzzo LV
J Mol Diagn; 2013 Mar; 15(2):196-209. PubMed ID: 23273604
[TBL] [Abstract][Full Text] [Related]
12. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
[TBL] [Abstract][Full Text] [Related]
13. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
Gunnarsson R; Isaksson A; Mansouri M; Göransson H; Jansson M; Cahill N; Rasmussen M; Staaf J; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Juliusson G; Rosenquist R
Leukemia; 2010 Jan; 24(1):211-5. PubMed ID: 19741724
[No Abstract] [Full Text] [Related]
14. Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
Saddler C; Ouillette P; Kujawski L; Shangary S; Talpaz M; Kaminski M; Erba H; Shedden K; Wang S; Malek SN
Blood; 2008 Feb; 111(3):1584-93. PubMed ID: 17971485
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
[TBL] [Abstract][Full Text] [Related]
16. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
[TBL] [Abstract][Full Text] [Related]
17. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
Ojha J; Ayres J; Secreto C; Tschumper R; Rabe K; Van Dyke D; Slager S; Shanafelt T; Fonseca R; Kay NE; Braggio E
Blood; 2015 Jan; 125(3):492-8. PubMed ID: 25377784
[TBL] [Abstract][Full Text] [Related]
18. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
[TBL] [Abstract][Full Text] [Related]
19. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
[TBL] [Abstract][Full Text] [Related]
20. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
